Neoadjuvant chemoradiotherapy for esophageal carcinoma

Diseases of the Esophagus

Volumn 18, Issue 2, 2005, Pages 104-108

  Zhang, X ^a   Watson, David I ^a   Jamieson, G G ^b   Bessell, J R ^a   Devitt, P G ^b  

^a FLINDERS UNIVERSITY   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Chemotherapy; Esophageal carcinoma; Esophagectomy; Radiotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; EXPERIENCE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SURGICAL MORTALITY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 22144453572     PISSN: 11208694     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2005.00461.x     Document Type: Article

References (29)

1. Mariette C, Finzi L, Fabre S, Balon J M, Van Seuningen I, Triboulet J P. Factors predictive of complete resection of operable esophageal cancer: a prospective study. Ann Thorac Surg 2003; 75: 1720-6.
2. Hagen J A, DeMeester S R, Peters J H, Chandrasoma P, DeMeester T R. Curative resection for esophageal adenocarcinoma. analysis of 100 en bloc esophagectomies. Ann Surg 2001; 234: 520-31.
3. Altorki N, Skinner D. Should en bloc esophagectomy be the standard of care for esophageal carcinoma? Ann Surg 2001; 234: 581-7.
4. Orringer M B, Marshall B, Iannettoni M D. Transhiatal esophagectomy for treatment of benign and malignant esophageal disease. World J Surg 2001; 25: 196-203.
5. Ando N, Iizuka T, Ide H et al. Japan Clinical Oncology Group. A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study. J Thorac Cardiovasc Surg 1997; 114: 205-9.
6. Bains M S, Stojadinovic A, Minsky B et al. A phase II trial of preoperative combined-modality therapy for localized esophageal carcinoma: initial results. J Thorac Cardiovasc Surg 2002; 124: 270-7.
7. Coia L R, Minsky B D, Berkey B A et al. Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-94 patterns of care study. J Clin Oncol 2000; 18: 455-62.
8. Urschel J D, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003; 185: 538-43.
9. Smithers B M, Devitt P, Jamieson G G et al. A combined modality approach to the management of esophageal cancer. Eur J Surg Oncol 1997; 23: 219-23.
10. O'Sullivan G C, Sheehan D, Clarke A et al. Micrometastases in esophagogastric, cancer: high detection rate in resected rib segments. Gastroenterology 1999; 116: 543-8.
11. Brown W A, Thomas J, Gotley D et al. Use of oesophagogastroscopy to assess the response of oesphageal carcinoma to neoadjuvant therapy. Br J Surg 2004; 91: 199-204.
12. Mathew G, Jamieson G G. Neoadjuvant therapy for esophageal cancer. Br J Surg 1997; 84: 1185-7.
13. Slater M S, Holland J, Faigel D O, Sheppard B C, Deveney C W. Does neoadjuvant chemoradiation downstage esophageal carcinoma? Am J Surg 2001; 181: 440-4.
14. Meneu-Diaz J C, Blazquez L A, Vicente E et al. The role of multimodality therapy for respectable esophageal cancer. Am J Surg 2000; 179: 308-13.
15. Lee J L, Kim S B, Jung H Y et al. Efficacy of neoadjuvant chemoradiotherapy in respectable esophageal squamous cell carcinoma - a single institutional study. Acta Oncol 2003; 42: 207-17.
16. Guillem P, Fabre S, Mariette C, Triboulet J P. Surgery after induction chemoradiotherapy for esophageal cancer. Eur J Surg Oncol 2003; 29: 158-65.
17. Noguchi T, Moriyama H, Wada S et al. Resection surgery with neoadjuvant chemoradiotherapy improves outcomes of patients with T4 esophageal carcinoma. Dis Esoph 2003; 16: 94-8.
18. Shiozaki H, Yano M. [Neoadjuvant chemoradiotherapy in patients with surgically treated T4 esophageal squamous cell carcinoma.] Nippon Geka Gakkai Zasshi 2002; 103: 284-9. (In Japanese.)
19. Lerut T, Coosemans W, Decker G, De Leyn P, Nafteux P, Van Raemodonck D. Cancer of the esophagus and gastroesophageal junction: potentially curative therapies. Surg Oncol 2001; 10: 113-22.
20. Arnott S J, Duncan W, Gignoux M et al. Preoperative radiotherapy in esophageal carcinoma: a meta-analysis using individual patient data (Esophageal Cancer Collaborative Group). Int J Radiat Oncol Biol Phys 1998; 41: 579-83.
21. Makary M A, Kiernan P D, Sheridan M J et al. Multimodality treatment for esophageal cancer: the role of surgery and neoadjuvant therapy. Am Surg 2003; 69: 693-700.
22. Vermund H, Pories W J, Hillard J, Wiley A L, Youngblood R. Neoadjuvant chemoradiation therapy in patients with surgically treated esophageal cancer. Acta Oncol 2001; 40: 558-65.
23. Takahashi S, Sato Y, Kondo M et al. Neoadjuvant chemoradiotherapy for advanced squamous cell carcinoma of thoracic esophagus. Gan Kagaku Ryoho 2004; 31: 45-9.
24. Urba S G, Orringer M B, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001; 19: 305-13.
25. Walsh T N, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy T P. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335: 462-7.
26. Smithers B M, Burmeister B H, Fitzgerald L et al. A randomized phase III trial of surgery alone compared with chemoradiation & surgery: a focus on the surgical outcomes. Ann Surg Oncol 2003; 10: S10 (Abstract).
27. Cooper J S, Guo M D, Herskovic, A et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Ther Oncol Group JAMA 1999; 281: 1623-7.
28. Tomasich F D, Valladares G C, Demarchi V C, Gagliardi D. Influence of neoadjuvant treatment on morbidity-mortality of esophagectomy. Assoc Med Bras 2003; 49: 300-5.
29. Kelley S T, Coppola D, Karl R C. Neoadjuvant chemoradiotherapy is not associated with a higher complication rate vs. surgery alone in patients undergoing esophagectomy. J Gastrointest Surg 2004; 8: 227-32.